Found: 2

Select item for more details and to access through your institution.

  • PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.

    Published in:
    Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1121973
    By:
    • van Amerongen, Rosa A.;
    • Tuit, Sander;
    • Wouters, Anne K.;
    • van de Meent, Marian;
    • Siekman, Sterre L.;
    • Meeuwsen, Miranda H.;
    • Wachsmann, Tassilo L. A.;
    • Remst, Dennis F. G.;
    • Hagedoorn, Renate S.;
    • van der Steen, Dirk M.;
    • de Ru, Arnoud H.;
    • Verdegaal, Els M. E.;
    • van Veelen, Peter A.;
    • Falkenburg, J. H. Frederik;
    • Heemskerk, Mirjam H. M.
    Publication type:
    Article

  • Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

    Published in:
    Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01408-6
    By:
    • Meeuwsen, Miranda H.;
    • Wouters, Anne K.;
    • Wachsmann, Tassilo L. A.;
    • Hagedoorn, Renate S.;
    • Kester, Michel G. D.;
    • Remst, Dennis F. G.;
    • van der Steen, Dirk M.;
    • de Ru, Arnoud H.;
    • van Hees, Els P.;
    • Kremer, Martijn;
    • Griffioen, Marieke;
    • van Veelen, Peter A.;
    • Falkenburg, J. H. Frederik;
    • Heemskerk, Mirjam H. M.
    Publication type:
    Article